Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Diabetic cardiomyopathy
Page 1 of 1 ( 34 items )
<<
1
>>
1
Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy
1/14/2026 8:09:14 AM |
Browse: 7 |
Download: 65
2
Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component?
1/14/2026 8:09:13 AM |
Browse: 11 |
Download: 54
3
Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway
12/15/2025 9:46:09 AM |
Browse: 25 |
Download: 131
4
Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy
12/15/2025 9:46:06 AM |
Browse: 37 |
Download: 91
5
Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study
10/15/2025 9:03:23 AM |
Browse: 50 |
Download: 249
6
Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography
10/15/2025 9:03:21 AM |
Browse: 45 |
Download: 141
7
Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells
9/11/2025 9:41:58 AM |
Browse: 277 |
Download: 282
8
Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy
6/13/2025 11:47:55 AM |
Browse: 45 |
Download: 336
9
Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies
2/28/2025 10:47:24 AM |
Browse: 128 |
Download: 439
10
Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure
1/21/2025 6:56:34 AM |
Browse: 76 |
Download: 400
11
Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management
11/26/2024 9:16:41 AM |
Browse: 60 |
Download: 395
12
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
11/18/2024 3:30:39 AM |
Browse: 103 |
Download: 492
13
Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy
9/26/2024 8:51:02 AM |
Browse: 97 |
Download: 691
14
Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy
9/26/2024 8:51:01 AM |
Browse: 117 |
Download: 721
15
Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
8/27/2024 3:11:19 PM |
Browse: 131 |
Download: 657
16
Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure
8/26/2024 12:59:17 PM |
Browse: 24 |
Download: 117
17
Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis
7/26/2024 6:56:09 AM |
Browse: 97 |
Download: 561
18
Diabetic cardiomyopathy: Emerging therapeutic options
7/26/2024 6:56:09 AM |
Browse: 167 |
Download: 498
19
Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy
6/11/2024 2:35:35 PM |
Browse: 116 |
Download: 586
20
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
4/12/2024 1:04:39 AM |
Browse: 131 |
Download: 1150
21
Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway
12/14/2023 9:36:12 AM |
Browse: 264 |
Download: 1297
22
Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization
12/14/2023 9:36:12 AM |
Browse: 260 |
Download: 1103
23
Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid
12/14/2023 9:36:11 AM |
Browse: 318 |
Download: 895
24
Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology
11/14/2023 6:13:55 AM |
Browse: 261 |
Download: 1205
25
Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy
5/13/2022 10:36:57 AM |
Browse: 672 |
Download: 1576
26
Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury
4/14/2022 11:27:05 AM |
Browse: 624 |
Download: 1897
27
Role of novel biomarkers in diabetic cardiomyopathy
6/4/2021 1:47:10 PM |
Browse: 747 |
Download: 1711
28
Diabetic heart disease: A clinical update
4/9/2021 5:27:04 AM |
Browse: 588 |
Download: 1544
29
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
10/15/2019 3:36:45 AM |
Browse: 907 |
Download: 1470
30
Trace elements in diabetic cardiomyopathy: An electrophysiological overview
9/1/2014 3:13:00 PM |
Browse: 1344 |
Download: 1317
31
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management
9/1/2014 3:02:00 PM |
Browse: 1215 |
Download: 1225
32
Cardiac autonomic neuropathy in patients with diabetes mellitus
9/1/2014 12:00:00 PM |
Browse: 1615 |
Download: 1599
33
Is diabetic cardiomyopathy a specific entity?
8/27/2014 5:24:00 PM |
Browse: 1038 |
Download: 1119
34
Mechanisms underlying the impaired contractility of diabetic cardiomyopathy
8/22/2014 2:47:00 PM |
Browse: 1135 |
Download: 1208
Page 1 of 1 ( 34 items )
<<
1
>>
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345